Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on June 4, 2026

11 hours ago

Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans

Indeterminate GlobeNewswire

11 hours ago

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum

Indeterminate GlobeNewswire

11 hours ago

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire

11 hours ago

Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory

Indeterminate GlobeNewswire

11 hours ago

Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy

Indeterminate GlobeNewswire

11 hours ago

Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society

Indeterminate GlobeNewswire

12 hours ago

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Indeterminate GlobeNewswire

12 hours ago

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Indeterminate GlobeNewswire

12 hours ago

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire

12 hours ago

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Indeterminate GlobeNewswire

12 hours ago

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire

12 hours ago

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire

12 hours ago

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Indeterminate GlobeNewswire

12 hours ago

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

Indeterminate GlobeNewswire

12 hours ago

Breckenridge Distillery Introduces Breckenridge Rye Whiskey, A Bold New Expression from the World’s Highest Distillery

Indeterminate GlobeNewswire

12 hours ago

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire

12 hours ago

Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO

Indeterminate GlobeNewswire

12 hours ago

LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit

Indeterminate GlobeNewswire

12 hours ago

GH Research Announces Publication of Phase 2a Postpartum Depression Results

Indeterminate GlobeNewswire